Clinical Efficacy of Mouthrinses Based on Chlorhexidine 0.12% and CITROX® - Trial NCT06341439
Access comprehensive clinical trial information for NCT06341439 through Pure Global AI's free database. This phase not specified trial is sponsored by University of L'Aquila and is currently Recruitment Completed. The study focuses on Periodontitis. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of L'Aquila
Timeline & Enrollment
N/A
Feb 18, 2023
Mar 30, 2024
Primary Outcome
Probing Depth (PD),Gingival Index (GI),Plaque Index (PI),Full mouth plaque score (FMPS),Full mouth bleeding score (FMBS)
Summary
The goal of the following clinical trial is to compare the efficacy of a product based on
 chlorhexidine 0.12% and CITROX and the same product without CITROX in the healing phenomena
 that occur after non-surgical periodontal therapy. The main questions it aims to answer are:
 
 - Is the response to periodontal therapy better if mouthwash containing Citrox is used?
 
 - What is the patients' perception?
 
 Participants, divided into 2 groups, are asked to use either one or the other mouthwash for
 14 days after non-surgical periodontal therapy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06341439
Device Trial